Proton MRS may predict AED response in patients with TLE

Epilepsia

Volumn 51, Issue 5, 2010, Pages 783-788

  Campos, Bruno A G ^a   Yasuda, Clarissa L ^a   Castellano, Gabriela ^a   Bilevicius, Elizabeth ^a   Li, Li M ^a   Cendes, Fernando ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

1H MRS; Antiepileptic drugs; Seizures; Temporal lobe epilepsy

Indexed keywords

ANTICONVULSIVE AGENT; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROENCEPHALOGRAPHY; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TEMPORAL LOBE EPILEPSY;

EID: 77951595802     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2009.02379.x     Document Type: Article

References (39)

1. Achten E, Santens P, Boon P, De Coo D, Van De Kerckhove T, De Reuck J, Caemaert J, Kunnen M. (1998) Single-voxel proton MR spectroscopy and positron emission tomography for lateralization of refractory temporal lobe epilepsy. AJNR Am J Neuroradiol 19:1-8. (Pubitemid 30430576)
2. Benedek K, Juhasz C, Muzik O, Chugani DC, Chugani HT. (2004) Metabolic changes of subcortical structures in intractable focal epilepsy. Epilepsia 45:1100-1105. (Pubitemid 39238121)
3. Bernasconi A, Bernasconi N, Caramanos Z, Reutens DC, Andermann F, Dubeau F, Tampieri D, Pike BG, Arnold DL. (2000) T2 relaxometry can lateralize mesial temporal lobe epilepsy in patients with normal MRI. Neuroimage 12:739-746.
4. Betting LE, Kobayashi E, Montenegro MA, Min LL, Cendes F, Guerreiro MM, Guerreiro CA. (2003) Treatment of epilepsy: consensus of the Brazilian specialists. Arq Neuropsiquiatr 61:1045-1070. (Pubitemid 38009322)
5. Bonilha L, Rorden C, Castellano G, Pereira F, Rio PA, Cendes F, Li LM. (2004) Voxel-based morphometry reveals gray matter network atrophy in refractory medial temporal lobe epilepsy. Arch Neurol 61:1379-1384. (Pubitemid 39202220)
6. Bonilha L, Rorden C, Castellano G, Cendes F, Li LM. (2005) Voxel-based morphometry of the thalamus in patients with refractory medial temporal lobe epilepsy. Neuroimage 25:1016-1021. (Pubitemid 40461738)
7. Briellmann RS, Mark Wellard R, Masterton RA, Abbott DF, Berkovic SF, Jackson GD. (2007) Hippocampal sclerosis: MR prediction of seizure intractability. Epilepsia 48:315-323. (Pubitemid 46213884)
8. Cendes F, Andermann F, Dubeau F, Matthews PM, Arnold DL. (1997) Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy. Evidence from proton MR spectroscopic imaging. Neurology 49:1525-1533.
9. Cendes F, Knowlton R, Novotny E, Li L, Antel S, Sawrie S, Laxer K, Arnold D. (2002) Magnetic resonance spectroscopy in epilepsy: clinical issues. Epilepsia 43(suppl 1):32-39. (Pubitemid 34215473)
10. Clark JB. (1998) N-acetyl aspartate: a marker for neuronal loss or mitochondrial dysfunction. Dev Neurosci 20:271-276.
11. Connelly A, Van Paesschen W, Porter DA, Johnson CL, Duncan JS, Gadian DG. (1998) Proton magnetic resonance spectroscopy in MRI-negative temporal lobe epilepsy. Neurology 51:61-66. (Pubitemid 28345360)
12. Dlugos DJ, Sammel MD, Strom BL, Farrar JT. (2001) Response to first drug trial predicts outcome in childhood temporal lobe epilepsy. Neurology 57:2259-2264.
13. Doelken MT, Stefan H, Pauli E, Stadlbauer A, Struffert T, Engelhorn T, Richter G, Ganslandt O, Doerfler A, Hammen T. (2008) (1)H-MRS profile in MRI positive- versus MRI negative patients with temporal lobe epilepsy. Seizure 17:490-497.
14. Duc CO, Trabesinger AH, Weber OM, Meier D, Walder M, Wieser HG, Boesiger P. (1998) Quantitative 1H MRS in the evaluation of mesial temporal lobe epilepsy in vivo. Magn Reson Imaging 16:969-979. (Pubitemid 28499018)
15. Engel J Jr. (2001) A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 42:796-803. (Pubitemid 32605946)
16. Gomes WA, Lado FA, de Lanerolle NC, Takahashi K, Pan C, Hetherington HP. (2007) Spectroscopic imaging of the pilocarpine model of human epilepsy suggests that early NAA reduction predicts epilepsy. Magn Reson Med 58:230-235. (Pubitemid 47267639)
17. Hammen T, Schwarz M, Doelken M, Kerling F, Engelhorn T, Stadlbauer A, Ganslandt O, Nimsky C, Doerfler A, Stefan H. (2007) 1H-MR spectroscopy indicates severity markers in temporal lobe epilepsy: correlations between metabolic alterations, seizures, and epileptic discharges in EEG. Epilepsia 48:263-269. (Pubitemid 46213878)
18. Hetherington HP, Kuzniecky RI, Vives K, Devinsky O, Pacia S, Luciano D, Vasquez B, Haut S, Spencer DD, Pan JW. (2007) A subcortical network of dysfunction in TLE measured by magnetic resonance spectroscopy. Neurology 69:2256-2265. (Pubitemid 350294682)
19. King D, Spencer SS, McCarthy G, Luby M, Spencer DD. (1995) Bilateral hippocampal atrophy in medial temporal lobe epilepsy. Epilepsia 36:905-910.
20. Kobau R, Zahran H, Grant D, Thurman DJ, Price PH, Zack MM. (2007) Prevalence of active epilepsy and health-related quality of life among adults with self-reported epilepsy in California: California Health Interview Survey, 2003. Epilepsia 48:1904-1913. (Pubitemid 47537441)
21. Kuzniecky R, Palmer C, Hugg J, Martin R, Sawrie S, Morawetz R, Faught E, Knowlton R. (2001) Magnetic resonance spectroscopic imaging in temporal lobe epilepsy: neuronal dysfunction or cell loss? Arch Neurol 58:2048-2053.
22. Kwan P, Brodie MJ. (2000) Early identification of refractory epilepsy. N Engl J Med 342:314-319.
23. Kwan P, Sander JW. (2004) The natural history of epilepsy: an epidemiological view. J Neurol Neurosurg Psychiatry 75:1376-1381. (Pubitemid 39279801)
24. Li LM, Cendes F, Andermann F, Dubeau F, Arnold DL. (2000) Spatial extent of neuronal metabolic dysfunction measured by proton MR spectroscopic imaging in patients with localization-related epilepsy. Epilepsia 41:666-674. (Pubitemid 30390417)
25. McMillan AB, Hermann BP, Johnson SC, Hansen RR, Seidenberg M, Meyerand ME. (2004) Voxel-based morphometry of unilateral temporal lobe epilepsy reveals abnormalities in cerebral white matter. Neuroimage 23:167-174. (Pubitemid 39119446)
26. Melcon MO, Kochen S, Vergara RH. (2007) Prevalence and clinical features of epilepsy in Argentina. A community-based study. Neuroepidemiology 28:8-15.
27. Noronha AL, Borges MA, Marques LH, Zanetta DM, Fernandes PT, de Boer H, Espindola J, Miranda CT, Prilipko L, Bell GS, Sander JW, Li LM. (2007) Prevalence and pattern of epilepsy treatment in different socioeconomic classes in Brazil. Epilepsia 48:880-885. (Pubitemid 46763425)
28. Picot MC, Baldy-Moulinier M, Daures JP, Dujols P, Crespel A. (2008) The prevalence of epilepsy and pharmacoresistant epilepsy in adults: a population-based study in a Western European country. Epilepsia 49:1230-1238. (Pubitemid 351991393)
29. Placencia M, Shorvon SD, Paredes V, Bimos C, Sander JW, Suarez J, Cascante SM. (1992) Epileptic seizures in an Andean region of Ecuador. Incidence and prevalence and regional variation. Brain 115(Pt 3):771-782.
30. Quigg M, Bertram EH, Jackson T, Laws E. (1997) Volumetric magnetic resonance imaging evidence of bilateral hippocampal atrophy in mesial temporal lobe epilepsy. Epilepsia 38:588-594.
31. Riederer F, Bittsansky M, Schmidt C, Mlynarik V, Baumgartner C, Moser E, Serles W. (2006) 1H magnetic resonance spectroscopy at 3 T in cryptogenic and mesial temporal lobe epilepsy. NMR Biomed 19:544-553. (Pubitemid 44240779)
32. Riederer F, Bittsansky M, Lehner-Baumgartner E, Baumgartner C, Mlynarik V, Gruber S, Moser E, Kaya M, Serles W. (2007) Decrease of NAA with aging outside the seizure focus in mesial temporal lobe epilepsy - a proton-MRS study at 3 Tesla. Brain Res 1179:131-139. (Pubitemid 47633504)
33. Riederer F, Lanzenberger R, Kaya M, Prayer D, Serles W, Baumgartner C. (2008) Network atrophy in temporal lobe epilepsy: a voxel-based morphometry study. Neurology 71:419-425.
34. Someya Y, Obata T, Suhara T, Ota Y, Ikehira H, Tanada S, Hirakawa K, Okubo Y, Sasaki Y. (2000) Seizure frequency and bilateral temporal abnormalities: a proton magnetic resonance spectroscopy of temporal lobe epilepsy. Seizure 9:274-279. (Pubitemid 30427137)
35. Urenjak J, Williams SR, Gadian DG, Noble M. (1993) Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 13:981-989. (Pubitemid 23067586)
36. Vermathen P, Laxer KD, Schuff N, Matson GB, Weiner MW. (2003) Evidence of neuronal injury outside the medial temporal lobe in temporal lobe epilepsy: N-acetylaspartate concentration reductions detected with multisection proton MR spectroscopic imaging-initial experience. Radiology 226:195-202. (Pubitemid 36163929)
37. Vielhaber S, Niessen HG, Debska-Vielhaber G, Kudin AP, Wellmer J, Kaufmann J, Schonfeld MA, Fendrich R, Willker W, Leibfritz D, Schramm J, Elger CE, Heinze HJ, Kunz WS. (2008) Subfield-specific loss of hippocampal N-acetyl aspartate in temporal lobe epilepsy. Epilepsia 49:40-50.
38. Woermann FG, McLean MA, Bartlett PA, Parker GJ, Barker GJ, Duncan JS. (1999) Short echo time single-voxel 1H magnetic resonance spectroscopy in magnetic resonance imaging-negative temporal lobe epilepsy: different biochemical profile compared with hippocampal sclerosis. Ann Neurol 45:369-376.
39. Zhao Y, Zhang Q, Tsering T, Sangwan , Hu X, Liu L, Shang H, Chen Q, Liu Y, Yang X, Wang W, Li S, Wu J, Sander JW, Zhou D. (2008) Prevalence of convulsive epilepsy and health-related quality of life of the population with convulsive epilepsy in rural areas of Tibet Autonomous Region in China: an initial survey. Epilepsy Behav 12:373-381.